Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology TrialsChristopher L. Hallemeier, Christopher H. Crane, Jennifer Moughan et al.|JAMA Network Open|2023Cited by 17
Initial safety assessment of the endoscopically injected oncolytic virus OBP-301 in medically inoperable esophageal cancer: NRG-GI007.Geoffrey Y. Ku, Theodore S. Hong, Jennifer Moughan et al.|Journal of Clinical Oncology|2024Cited by 1
Impact of radiotherapy duration on outcomes in patients with esophageal cancer treated with definitive concurrent radiotherapy and chemotherapy on RTOG trials 8501 and 9405.Christopher L. Hallemeier, Christopher H. Crane, Jennifer Moughan et al.|Journal of Clinical Oncology|2015Cited by 0
NRG-GI007: Secondary endpoints of safety assessment and clinical complete response (cCR) of chemoradiation with endoscopically injected oncolytic virus OBP-301 in medically inoperable esophageal cancer.Geoffrey Y. Ku, Theodore S. Hong, Terence M. Williams et al.|Journal of Clinical Oncology|2025Cited by 0
NRG-GI007: Phase 1 Study of OBP-301, An Oncolytic Virus, and Definitive Chemoradiation in Locally Advanced Esophageal CancerGeoffrey Y Ku, Terence M Williams, Kathryn Winter et al.|International Journal of Radiation Oncology*Biology*Physics|2026Cited by 0